Search for a Neurobloc ® clinic in your local area.
Neurobloc® became available in the U.K. in 2001.
There is limited experience in the use of this type of toxin, and the product does not currently have approval for cosmetic use anywhere in the world.
As a result of this very few U.K. practitioners have any experience in the use of this product for lines and wrinkles.
Clostridium botulinum type - B neurotoxin complex
Neurobloc® is made from purified type - B neurotoxin produced by the bacteria Clostridium botulinum.
It temporarily prevents the release of acetycholine from sympathetic nerve terminals.
Prescription only medicine
It should be used by trained members of the medical profession only.
Individuals with a known hypersensitivity to any component of the formulation.
Patients who have generalised disorders of muscle activity (e.g. myasthenia gravis).
Patients where aminoglycoside antibiotics or spectinomycin are already being used or are likely to be used.
Patients who have bleeding disorders of any type.
Pregnant or lactating women.
Data not available
Neurobloc® is a registered trademark of Solstice Neurosciences Inc.